Extreme polypharmacy: The need to mint a new term
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4942
Abstract: The increasing number of drugs that are released annually to the market and their progressive use in people who have multiple morbidities, which is promoted by clinical practice guidelines to achieve control goals based on… read more here.
Keywords: use; patients extreme; number; polypharmacy ... See more keywords
Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-017-0855-6
Abstract: BackgroundWe evaluated the performance of stress imaging with technetium-99m-labeled tetrofosmin single-photon emission computed tomography (SPECT) and rubidium-82 positron emission tomography (PET) in patients with extreme obesity, defined as body mass index ≥40 kg/m2.MethodsWe identified patients with… read more here.
Keywords: pet; spect pet; patients extreme; performance ... See more keywords
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1718413
Abstract: Although nonvitamin K antagonist oral anticoagulants (NOACs) have generally shown comparable efficacy and better safety compared with warfarin, atrial fibrillation (AF) patients with extreme body weights have been underrepresented in pivotal clinical trials. Low-body-weight (LBW)… read more here.
Keywords: body weights; extreme body; asian patients; safety ... See more keywords
Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221130456
Abstract: Objective: The objective of the study was to discuss the controversies surrounding the use and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the limitations of the existing evidence base that preclude strong… read more here.
Keywords: patients extreme; obese patients; acting oral; dilemmas related ... See more keywords